Compare DGII & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | ENOV |
|---|---|---|
| Founded | 1985 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Fluid Controls |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | 2008 |
| Metric | DGII | ENOV |
|---|---|---|
| Price | $43.02 | $22.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $48.80 | $48.13 |
| AVG Volume (30 Days) | 249.7K | ★ 1.0M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | $430,221,000.00 | ★ $2,233,266,000.00 |
| Revenue This Year | $12.80 | $9.22 |
| Revenue Next Year | $5.47 | $4.60 |
| P/E Ratio | $39.69 | ★ N/A |
| Revenue Growth | 1.46 | ★ 11.57 |
| 52 Week Low | $22.39 | $22.50 |
| 52 Week High | $48.00 | $49.38 |
| Indicator | DGII | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 29.93 |
| Support Level | $42.10 | $22.50 |
| Resistance Level | $44.19 | $24.46 |
| Average True Range (ATR) | 1.36 | 1.26 |
| MACD | -0.06 | -0.34 |
| Stochastic Oscillator | 63.35 | 0.06 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.